pSivida (ASX:PVA) will this week make presentations at the Rodman & Renshaw Annual Global Investment Conference and the Stifel Nicolaus Healthcare Conference. [ + ]

iSonea (ASX:ISN) has gained the certification required for a CE Mark for its AirSonea wheeze monitoring tool, paving the way for an EU launch following its debuts in Australia and the US. [ + ]

CleanUp 2013 will be held from 15-18 September 2013 at the Crown Conference Centre, Melbourne. Leading international scientists will attend the event to discuss the latest tactics and solutions in the growing worldwide war on pollution. [ + ]

An enzyme that 'unravels' DNA plays a key role in male development of the embryo and may provide greater insight into intersex conditions. [ + ]

Brisbane-based biotech Dendright has appointed Helen Roberts as CEO. [ + ]

Genea Biomedx's Gavi (Genea Automated Vitrification Instrument) was launched to fertility specialists, scientists and nurses at the Fertility Society of Australia conference in Sydney yesterday. It is said that the Australian invention will revolutionise one of the key IVF processes by removing the risk of human error. [ + ]

An international consortium of scientists, including researchers from the University of Western Australia (UWA), has made a major breakthrough in understanding the genetic basis of schizophrenia - a complex mental disorder which affects about 1% of people over their lifetime. [ + ]

The custodian of the world’s longest running laboratory experiment, Professor John Mainstone, has died at the age of 78 after suffering a stroke. The former Head of the University of Queensland’s (UQ) Department of Physics was the guardian of the world-famous pitch drop experiment. [ + ]

Australian innovators are being given an extended opportunity to showcase their bright ideas, with the entry deadline for the $70,000 The Australian Innovation Challenge being moved to 23 September. [ + ]

Coridon, Allied Healthcare's (ASX:AHZ) 50.1%-owned subsidiary, said no safety issues were raised during dosing of the first two cohorts in a phase I study of its herpes vaccine and treatment. [ + ]

The Advisory Council on Intellectual Property (ACIP) has just released an Options Paper for its Review of the Innovation Patent System. ACIP is seeking stakeholder comments on policy issues that address the full range of possibilities for the innovation patent system. [ + ]

Shell company Telesso (ASX:TEO) aims to raise up to $6.5m to help support its plan to acquire Mimetica, take on the company's name and fund phase II trials for Mimetica's acne drug candidate. [ + ]

Revenue from fonadaparinux sales and R&D Tax Incentive benefits helped Alchemia (ASX:ACL) reduce its FY13 loss by more than 68% to $4.8m. [ + ]

Genetic Technologies (ASX:GTG) has received the approval required to launch breast cancer test BREVAGen in NY, meaning the company can now provide the product in all 50 US states. [ + ]

Inspired by coiled nanostructures in butterfly wings, researchers have developed a photonic crystal that could steer optical communications technologies in a faster direction. [ + ]